List of companies in Logos Capital's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Novartis is a healthcare and pharmaceutical company based in Basel, Switzerland, incorporated in 1996. | ||||||
Silicon Valley-based genetic engineering startup. | ||||||
Develops novel cell and gene therapies with pharmacologic operating systems. | ||||||
Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies. | ||||||
Focused on transforming lives of patients with immune dysfunctions and cancer | ||||||
Cullinan Oncology is an In-Licensing & Developing Oncology Assets for Sale founded in 2017. | ||||||
Avidity Biosciences is a biotechnology company developing RNA-based therapeutics that is headquartered in San Diego, California. | ||||||
Verve Therapeutics is a company in Cambridge, Massachusetts. | ||||||
Pliant Therapeutics is a clinical-stage biopharmaceutical company developing treatments for fibrotic diseases with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway. | ||||||
Kymera Therapeutics is a Cambridge, Massachusetts-based biotechnology company specialized in the field of targeted protein degradation. | ||||||
Small Molecules | ||||||
ALX Oncology is a Burlingame, California-based biotechnology company working on pre-clinical stage immuno-oncology therapies. | ||||||
Century Therapeutics is a company that manufactures a novel allogeneic iPSC-derived natural killer (NK) and T cell products. | ||||||
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders. | ||||||
Kinnate Biopharma Inc. is a small Molecules founded by Nima Farzan. | ||||||
Boundless Bio is a pioneer in understanding and treating the most intractable cancers. They have charted a new spatial map of the cancer genome within cancer cells and are harnessing their scientific founders' discoveries about "extrachromosomal DNA," or ecDNA, to drive a revolution in cancer therapeutics. | ||||||
Annexon Biosciences is a South San Francisco, California-based biotechnology company working on discovering and developing therapeutics for neurodegenerative and autoimmune disorders. | ||||||
Passage Bio, Inc is a Philadelphia-based biotechnology company developing genetics-based medicines. | ||||||
Arbor Technologies is a company in Cambridge, MA, focusing on biodiscovery using machine learning, genome sequencing, gene synthesis and high-throughput screening. | ||||||
Repare Therapeutics is a synthetic Lethal Therapeutics founded in 2016 by Daniel Durocher, Agnel Sfeir and Frank Sicheri. | ||||||
Dyne Therapeutics is an Antibody-Oligonucleotide Treatments for Muscle Diseases founded in 2018. | ||||||
Vaccine Discovery Technology Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases. | ||||||
Nuvalent is creating precisely targeted therapies for patients with cancer. | ||||||
Edgewise Therapeutics is a drug discovery and biotechnology company developing products based on the understanding of skeletal muscle. | ||||||
Rain Therapeutics is a small Molecules founded in 2017 by Avanish Vellanki. |
